Form 8-K Summary
Business context and reporting period
Blue Water Biotech, Inc. filed a Form 8-K dated May 15, 2023 under Item 7.01 to disclose a schedule change for management’s presentation at the JMP Securities Life Sciences Conference. The filing does not report financial results for a specific quarter or year. The request metadata identifies Onconetix, Inc.; however, the filing text identifies the registrant as Blue Water Biotech, Inc.
Key financial metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating metrics, or other financial results. No clear financial values are included in the supplied filing text.
Material changes versus the prior comparable period
No period-over-period financial or operating comparison is provided. The material disclosed change is that the Company’s JMP Conference presentation time was moved from 3:30 p.m. EDT to 11:00 a.m. EDT on May 15, 2023.
Guidance, outlook, risks, contingencies, and unusual items
- Management was scheduled to present at the JMP Securities Life Sciences Conference at the New York Hilton Midtown on May 15, 2023.
- The presentation slides are furnished as Exhibit 99.1, but the supplied filing text does not include the contents of those slides.
- The Item 7.01 disclosure and presentation are furnished, not filed, and are not subject to liability under Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act.
- The disclosure and presentation will not be incorporated by reference into other SEC filings, regardless of general incorporation language.
- No financial guidance, risk update, contingency, debt-related matter, or unusual accounting item is disclosed in the filing text.
Important facts to verify
- Confirm the registrant’s legal name and whether this filing should be associated with Blue Water Biotech, Inc. or Onconetix, Inc.
- Review Exhibit 99.1 for any business outlook, pipeline updates, financial information, or risk commentary presented to investors.
- Verify the revised presentation time and any subsequent presentation or conference materials.
- Consult the Company’s periodic reports for financial results, liquidity, capital structure, and going-concern or financing information not included in this 8-K.